Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract Infections

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

2,810

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

July 31, 2012

Conditions
Acute Upper Respiratory Tract Infection
Interventions
DRUG

Mucinex

Mucinex combines immediate-release (IR) and modified-release guaifenesin in a bilayer tablet. Each tablet was 600 mg of guaifenesin and taken by mouth with a full glass of water.

DRUG

Immediate-release Guaifenesin

Each tablet was 200 mg of immediate-release (IR) guaifenesin and taken by mouth with a full glass of water.

DRUG

Placebo

Placebo tablets in two formulations to match either Mucinex or IR guaifenesin taken by mouth with a full glass of water

Trial Locations (43)

14609

Reckitt Benckiser Study Site, Rochester

27607

Reckitt Benckiser Study Site, Raleigh

29651

Reckitt Benckiser Study Site, Greer

32117

Reckitt Benckiser Study Site, Daytona Beach

32132

Reckitt Benckiser Study Site, Edgewater

33710

Reckitt Benckiser Study Site, Largo

35216

Reckitt Benckiser Study Site, Hoover

37067

Reckitt Benckiser Study Site, Franklin

37167

Reckitt Benckiser Study Site, Smyrna

37825

Reckitt Benckiser Study Site, New Tazewell

38305

Reckitt Benckiser Study Site, Jackson

40509

Reckitt Benckiser Study Site, Lexington

44130

Reckitt Benckiser Study Site, Middleburg Heights

45246

Reckitt Benckiser Study Site, Cincinnati

57049

Reckitt Benckiser Study Site, Dakota Dunes

60624

Reckitt Benckiser Study Site, Chicago

61761

Reckitt Benckiser Study Site, Normal

67207

Reckitt Benckiser Study Site, Wichita

68005

Reckitt Benckiser Study Site, Bellevue

68114

Reckitt Benckiser Study Site, Omaha

68134

Reckitt Benckiser Study Site, Omaha

70006

Reckitt Benckiser Study Site, Metairie

70115

Reckitt Benckiser Study Site, New Orleans

75010

Reckitt Benckiser Study Site, Carrollton

76135

Reckitt Benckiser Study Site, Forth Worth

76904

Reckitt Benckiser Study Site, San Angelo

77375

Reckitt Benckiser Study Site, Tomball

78705

Reckitt Benckiser Study Site, Austin

80239

Reckitt Benckiser Study Site, Denver

80907

Reckitt Benckiser Study Site, Colorado Springs

84124

Reckitt Benckiser Study Site, Salt Lake City

89102

Reckitt Benckiser Study Site, Las Vegas

89119

Reckitt Benckiser Study Site, Las Vegas

90201

Reckitt Benckiser Study Site, Bell Gardens

90710

Reckitt Benckiser Study Site, Harbor City

90813

Reckitt Benckiser Study Site, Long Beach

93405

Reckitt Benckiser Study Site, San Luis Obispo

94102

Reckitt Benckiser Study Site, San Francisco

95816

Reckitt Benckiser Study Site, Sacramento

99204

Reckitt Benckiser Study Site, Spokane

02135

Reckitt Benckiser Study Site, Brighton

02720

Reckitt Benckiser Study Site, Fall River

02886

Reckitt Benckiser Study Site, Warwick

All Listed Sponsors
lead

Reckitt Benckiser LLC

INDUSTRY

NCT01537081 - Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract Infections | Biotech Hunter | Biotech Hunter